harrison.ai and Sonic Healthcare join forces to launch 'frankl... - 06 July 2022 12:34

SYDNEY, July 6, 2022 /PRNewswire-AsiaNet/ -- franklin.ai aims to apply the latest methodologies in artificial intelligence (AI) to put groundbreaking AI tools into the hands of pathologists. harrison.ai(https://harrison.ai/), the clinically led healthcare AI platform and Sonic Healthcare(...

  Zsquare receives FDA Clearance to Market for First High-Perfor... - 06 July 2022 10:00

TEL AVIV, Israel, July 6, 2022 /PRNewswire-AsiaNet/ -- - Company's patented polymeric fiber is a breakthrough in the world of miniaturizing visualization - Zsquare ENT-Flex(TM) Rhinolaryngoscope advances the ENT category with a best-in-class 2.3mm outer diameter for high-resolution image quality at...

  NHS Scotland awards national laboratory medicine framework to ... - 05 July 2022 17:38

EDINBURGH, Scotland, July 5, 2022 /PRNewswire-AsiaNet/ -- Scotland is on its way to becoming home to the UK's largest connected laboratory medicine network, following the appointment of Citadel Health ( https://citadelhealth.co.uk/nhs-scotland-awards-national-laboratory-medicine-framework-to-citadel-heal...

  EditForce and Mitsubishi Tanabe Pharma Enter into License Agre... - 05 July 2022 17:00

FUKUOKA, Japan, July 5, 2022 /Kyodo JBN-AsiaNet/ -- EditForce, Inc. (Headquarters: Fukuoka, President and CEO: Takashi Ono; hereinafter "EditForce") has entered into a License Agreement (hereinafter "Agreement") with Mitsubishi Tanabe Pharma Corporation (Headquarters: Osaka, Representative Director...

  Octapharma shares new data at ISTH 2022 in its mission to meet... - 04 July 2022 20:00

LACHEN, Switzerland, July 4, 2022 /PRNewswire-AsiaNet/-- - Octapharma to present new clinical and scientific data from across Octapharma's haematology and critical care portfolios during the ISTH 2022 Congress - Data to be presented in 11 poster presentations and during two Supported Symposia - New da...

  Neuromod Publishes Results of Second Large Scale Clinical Tria... - 30 June 2022 21:00

DUBLIN, June 30, 2022 /PRNewswire-AsiaNet/ -- - Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire(R) - 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after ...

  New biomarkers unlock potential for more effective treatment o... - 30 June 2022 01:21

MADRID, June 29, 2022 /PRNewswire-AsiaNet/ -- - A new study focused on decoding the genetic chaos found in cancer cells is on the cover of the June issue of the scientific journal Nature. - This work reveals novel biomarkers with the potential to improve the development of precision therap...

  Tarkus, the Colombian phyto-therapeutic laboratory that is con... - 29 June 2022 09:51

BOGOTA, Colombia, June 29, 2022 /PRNewswire-AsiaNet/ -- -- Tarkus Pharma Lab, the first pharmaceutical laboratory located in a Free Trade Zone in Colombia, has become a global industry benchmark, developing raw materials and final products derived from medical cannabis with the highest quality, and exp...

  NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal... - 29 June 2022 01:50

MIAMI and FLORENCE, Italy and NAARDEN, Netherlands June 28, 2022 /PRNewswire-AsiaNet/ - Combines NewAmsterdam's lead clinical program obicetrapib with Menarini's deep cardiovascular disease and regional expertise - Total deal value of over 1 billion euros; including 142.5 million euros upfront payment and committed R&D funding pl...

  Amai Proteins, producer of 100% protein sweetener that reduces... - 28 June 2022 09:24

Palo Alto, Calif., June 28, 2022 /PRNewswire-AsiaNet/ -- Amai Proteins , an Israeli start-up developer of novel designer proteins that answer the needs of consumers and industry, is the Global Winner of the 2022 XTC competition. Extreme Tech Challenge (XTC) is the world's ...